Thomas Liggett

687 total citations
11 papers, 555 citations indexed

About

Thomas Liggett is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas Liggett has authored 11 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas Liggett's work include Multiple Sclerosis Research Studies (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer Genomics and Diagnostics (3 papers). Thomas Liggett is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer Genomics and Diagnostics (3 papers). Thomas Liggett collaborates with scholars based in United States, Italy and Japan. Thomas Liggett's co-authors include Anatoliy A. Melnikov, Victor Levenson, Qilong Yi, Dusan Stefoski, Jeffrey R. Marks, Roumen Balabanov, Karen L. Kaul, Randall E. Brand, Qilong Yi and Ross A. Abrams and has published in prestigious journals such as Journal of Neuroscience, The Journal of Immunology and Cancer.

In The Last Decade

Thomas Liggett

11 papers receiving 543 citations

Peers

Thomas Liggett
Rumana Rafiq United Kingdom
Srinivas Nandana United States
Noel C. Wortham United Kingdom
Elianna Amin United Kingdom
Rumana Rafiq United Kingdom
Thomas Liggett
Citations per year, relative to Thomas Liggett Thomas Liggett (= 1×) peers Rumana Rafiq

Countries citing papers authored by Thomas Liggett

Since Specialization
Citations

This map shows the geographic impact of Thomas Liggett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Liggett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Liggett more than expected).

Fields of papers citing papers by Thomas Liggett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Liggett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Liggett. The network helps show where Thomas Liggett may publish in the future.

Co-authorship network of co-authors of Thomas Liggett

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Liggett. A scholar is included among the top collaborators of Thomas Liggett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Liggett. Thomas Liggett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ogawa, Takenori, Thomas Liggett, Anatoliy A. Melnikov, et al.. (2012). Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance. Cell Cycle. 11(8). 1656–1663. 51 indexed citations
2.
Ren, Zhihua, Yan Wang, Tao Duan, et al.. (2012). Cross-Immunoreactivity between Bacterial Aquaporin-Z and Human Aquaporin-4: Potential Relevance to Neuromyelitis Optica. The Journal of Immunology. 189(9). 4602–4611. 31 indexed citations
3.
Ren, Zhihua, Yan Wang, Thomas Liggett, et al.. (2011). IRF-1 signaling in central nervous system glial cells regulates inflammatory demyelination. Journal of Neuroimmunology. 233(1-2). 147–159. 23 indexed citations
4.
Cassinotti, Elisa, Joshua Melson, Thomas Liggett, et al.. (2011). DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps. International Journal of Cancer. 131(5). 1153–1157. 73 indexed citations
5.
Ren, Zhiyong Jason, Yan Wang, Thomas Liggett, et al.. (2011). Overexpression of the Dominant-Negative Form of Interferon Regulatory Factor 1 in Oligodendrocytes Protects against Experimental Autoimmune Encephalomyelitis. Journal of Neuroscience. 31(23). 8329–8341. 26 indexed citations
6.
Liggett, Thomas, Anatoliy A. Melnikov, Qilong Yi, et al.. (2010). Differential methylation of cell‐free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer. 116(7). 1674–1680. 104 indexed citations
7.
Liggett, Thomas, Anatoliy A. Melnikov, Qilong Yi, et al.. (2010). Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors. Gynecologic Oncology. 120(1). 113–120. 95 indexed citations
8.
Liggett, Thomas, Anatoliy A. Melnikov, Qilong Yi, et al.. (2010). Methylation patterns of cell-free plasma DNA in relapsing–remitting multiple sclerosis. Journal of the Neurological Sciences. 290(1-2). 16–21. 76 indexed citations
9.
Ren, Zhihua, Yan Wang, Tao Duan, et al.. (2010). Central Nervous System Expression of Interferon Regulatory Factor 1 Regulates Experimental Autoimmune Encephalomyelitis. Journal of Neuroimmune Pharmacology. 5(2). 260–265. 7 indexed citations
10.
Liggett, Thomas, Anatoliy A. Melnikov, Jeffrey R. Marks, & Victor Levenson. (2010). Methylation patterns in cell‐free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients. International Journal of Cancer. 128(2). 492–499. 58 indexed citations
11.
Liggett, Thomas, T. Griffiths, & Elizabeth R. Gaillard. (2009). Isolation and characterization of a spontaneously immortalized bovine retinal pigmented epithelial cell line. BMC Cell Biology. 10(1). 33–33. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026